Journal of Clinical Endocrinology & Metabolism, Vol 57, 881-884, Copyright © 1983 by Endocrine Society

ARTICLES

Endogenous opioid regulation of gonadotropin-releasing hormone release from the human fetal hypothalamus in vitro

DD Rasmussen, JH Liu, PL Wolf and SS Yen

Endogenous opioid regulation of GnRH release from the human fetal (21- 23 weeks gestation) mediobasal hypothalamus was investigated in an in vitro perifusion system. Pulse injection of an opiate receptor antagonist, naloxone, reproducibly elicited an acute increase in GnRH release within 30 min. Constant infusion of naloxone (60 min) induced a sustained increase in GnRH release, which was promptly inhibited by a pulse of beta-endorphin administered halfway during the naloxone infusion. These studies unequivocally demonstrate that endogenous opiates exert an inhibitory effect on GnRH release from the human fetal mediobasal hypothalamus in vitro.

This article has been cited by other articles:

				A. C. Gore, B. M. Windsor-Engnell, and E. Terasawa Menopausal Increases in Pulsatile Gonadotropin-Releasing Hormone Release in a Nonhuman Primate (Macaca mulatta) Endocrinology, October 1, 2004; 145(10): 4653 - 4659. [Abstract] [Full Text] [PDF]

				S. Shridhar, A. Farley, R. L. Reid, W. G. Foster, and D. A. Van Vugt The Effect of 2,3,7,8-Tetrachlorodibenzo-p-dioxin on Corticotrophin-Releasing Hormone, Arginine Vasopressin, and Pro-opiomelanocortin mRNA Levels in the Hypothalamus of the Cynomolgus Monkey Toxicol. Sci., October 1, 2001; 63(2): 181 - 188. [Abstract] [Full Text] [PDF]

				R. Abs, J. Verhelst, J. Maeyaert, J.-P. Van Buyten, F. Opsomer, H. Adriaensen, J. Verlooy, T. Van Havenbergh, M. Smet, and K. Van Acker Endocrine Consequences of Long-Term Intrathecal Administration of Opioids J. Clin. Endocrinol. Metab., June 1, 2000; 85(6): 2215 - 2222. [Abstract] [Full Text]

				R. M. Sapolsky, L. M. Romero, and A. U. Munck How Do Glucocorticoids Influence Stress Responses? Integrating Permissive, Suppressive, Stimulatory, and Preparative Actions Endocr. Rev., February 1, 2000; 21(1): 55 - 89. [Abstract] [Full Text]

				A. P. Cemeroglu, G. B. Kletter, W. Guo, M. B. Brown, R. P. Kelch, J. C. Marshall, V. Padmanabhan, and C. M. Foster In Pubertal Girls, Naloxone Fails to Reverse the Suppression of Luteinizing Hormone Secretion by Estradiol J. Clin. Endocrinol. Metab., October 1, 1998; 83(10): 3501 - 3506. [Abstract] [Full Text]

				J. Hangaard, M. Andersen, E. Grodum, O. Koldkjær, and C. Hagen Pulsatile Luteinizing Hormone Secretion in Patients with Addison's Disease. Impact of Glucocorticoid Substitution J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 736 - 743. [Abstract] [Full Text]